article

European Pharmaceutical Review Issue 5 2021

Articles in this issue discuss the importance of diversity and inclusion in pharma, how packaging can improve big pharma’s bottom line and why innovation has been vital to saving lives during the COVID-19 pandemic. Also in this journal, 10 key considerations when creating an ATMP manufacturing facility and how to develop and deliver live biotherapeutic products, an emerging therapeutic modality.

In this journal:

  • BIOPROCESSING & BIOPRODUCTION
    Continuous biomanufacturing – where are we now?
    Hannah Balfour, European Pharmaceutical Review
  • FORMULATION, DEVELOPMENT & DELIVERY
    Maintaining EU MDR certification: a spotlight on post-market clinical follow-up
    Celeste Maksim, RQM+
  • MANUFACTURING, PACKAGING & LOGISTICS
    Formulation development of vitamin C-based effervescent blend suitable for direct compression
    Fabriano Ferrini, Federica Giatti and Caterina Funaro, IMA Active
  • QA/QC MICROBIOLOGY & CHROMATOGRAPHY
    The way ahead for chromatography systems after the pandemic
    Shreeras Shetty, Pharmaceutical industry content writer
    Real-time Transition Analysis curve in column chromatography with SIMCA®
    Pablo J Rosado, Melvin Ortiz, Badua Merheb and Alejandro Toro, Amgen Manufacturing Limited
Send this to a friend